• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

5

CATEGORIES

  • 10
  • 9
  • 7
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

9
17
20
32

PUBLISHED

1
3
9
32

PRODUCT TYPE

15
13
4

Search "Disease and Therapy Review: Irritable Bowel Syndrome" returned 32 results.

Irritable Bowel Syndrome - Pipeline Review, H2 2014

Irritable Bowel Syndrome - Pipeline Review, H2 2014 Summary This, ‘Irritable Bowel Syndrome - Pipeline Review, H2 2014’, provides an overview of the Irritable Bowel Syndrome’s therapeutic pipeline. This...

September 2014
FROM

Irritable Bowel Syndrome - Pipeline Review, H1 2014

Irritable Bowel Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Irritable Bowel Syndrome - Pipeline Review, H1 2014’, provides an overview of the Irritable Bowel Syndrome’s therapeutic...

March 2014
FROM

Irritable Bowel Syndrome - Pipeline Review, H1 2015

Irritable Bowel Syndrome - Pipeline Review, H1 2015 Summary This, ‘Irritable Bowel Syndrome - Pipeline Review, H1 2015’, provides an overview of the Irritable Bowel Syndrome’s therapeutic pipeline. This...

June 2015
FROM

Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Irritable Bowel Syndrome (IBS) Therapeutics in US$ Million The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of...

August 2011
FROM
Pain Therapeutics - Drugs, Markets and Companies Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic...

July 2015
FROM

IR Diagnostyx Inc. - Product Pipeline Analysis

IR Diagnostyx Inc. - Product Pipeline Analysis Summary IR Diagnostyx Inc. (IR Diagnostyx) is a pharmaceutical and healthcare company, based in the US. It specializes in providing rapid, accurate,...

June 2012
FROM

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated...

December 2014
FROM

ImmusanT, Inc. - Product Pipeline Analysis

Summary ImmusanT, Inc. (ImmusanT) is a biotechnology company. It focuses on the development of treatment, and diagnostic and monitoring tools for managing patients suffering from celiac disease. Celiac...

November 2012
FROM

Protagonist Therapeutics Inc. - Product Pipeline Review - 2014

Protagonist Therapeutics Inc. - Product Pipeline Review - 2014 Summary This, ‘Protagonist Therapeutics Inc. - Product Pipeline Review - 2014’, provides an overview of the Protagonist Therapeutics...

December 2014
FROM

Sucampo Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011

Sucampo Pharmaceuticals, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Sucampo Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011” provides...

October 2011
FROM

Lexicon Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011

Lexicon Pharmaceuticals, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Lexicon Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011” provides...

November 2011
FROM

X-BODY BioSciences, Inc. - Product Pipeline Review - 2014

X-BODY BioSciences, Inc. - Product Pipeline Review - 2014 Summary This, ‘X-BODY BioSciences, Inc. - Product Pipeline Review - 2014’, provides an overview of the X-BODY BioSciences, Inc.’s pharmaceutical...

December 2014
FROM

Autoimmune Disease Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple Sclerosis, Psoriasis, Crohns...

October 2011
FROM

Diarrhea - Pipeline Review, H1 2013

Diarrhea – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Diarrhea - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

March 2013
FROM
Probiotics - Global Strategic Business Report Probiotics - Global Strategic Business Report - Product Thumbnail Image

Probiotics - Global Strategic Business Report

This report analyzes the worldwide markets for Probiotics in US$ Million The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin...

May 2014
FROM

Lexicon Pharmaceuticals, Inc. - Product Pipeline Review - 2012

Lexicon Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Lexicon Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data...

May 2012
FROM

Diarrhea - Pipeline Review, H2 2013

Diarrhea - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Diarrhea - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

September 2013
FROM

Probiotics, Prebiotics, and Synbiotics

Probiotics, Prebiotics, and Synbiotics: Bioactive Foods in Health Promotion reviews and presents new hypotheses and conclusions on the effects of different bioactive components of probiotics, prebiotics,...

October 2015

Lexicon Pharmaceuticals, Inc. (LXRX) - Financial and Strategic SWOT Analysis Review

Lexicon Pharmaceuticals, Inc. (LXRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

May 2015
FROM

Neurocrine Biosciences, Inc. (NBIX) - Financial and Strategic SWOT Analysis Review

Neurocrine Biosciences, Inc. (NBIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

March 2015
FROM
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.